SSY Group Ltd is a specialty and generic drug manufacturing company. The company reports multiple segments including pharmaceutical products, medical materials, services income, raw materials, and by-products and rental income. The company derives a vast majority of its revenue principally from the sale of finished medicines to hospitals and distributors. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials. Over 95% of SSY Group's revenue and operating profits are derived from China.SSY Group Ltd is a pharmaceutical manufacturer which is engaged in the research, development, manufacturing and selling of pharmaceutical products. It offers finished medicines of intravenous infusion solution to hospitals and distributors.